ReviewWorld journal of diabetes2015

Ipragliflozin: A novel sodium-glucose cotransporter 2 inhibitor developed in Japan.

Tsuyoshi OhkuraPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.